Navigation Links
Man against HIV – new vaccine ready for human trials

A new vaccine called the TAT vaccine has been developed in Italy as the latest and most exciting HIV vaccine to date. And more importantly it has had a 71% success rate when tested on monkeys. This vaccine is now ready for human testing and this may be the brightest hope for mankind against the destructive HIV.

Dr.Barbara Ensoli, Head of the Department of Virology at Italy’s National Health Institute and Dr.Robert Gallo, one of the fathers of AIDS research have developed this vaccine which promises to be a strong salvo against the human immunodeficiency virus.

This project has consumed five years of dedicated work and employs an entirely new approach in tackling the virus. The idea is to block the virus from growing inside the body rather than trying to bolster the immune system against the virus as many vaccines try to do.

TAT protein is an important protein in the virus, which is a key building block of the dreaded virus. By blocking the TAT protein the scientists hope to stop the growth of the virus inside the human body. So they say this vaccine will be effective even in old cases of HIV. All eyes are now on the results of human testing of this vaccine to see how effective this could be.

The ability of the virus to mutate and survive has made it smart and strong to survive all the initiatives man has taken to eliminate it. The TAT vaccine is the latest hope for man against the virus! Lets hope this works!!
'"/>




Page: 1

Related medicine news :

1. Multi billion-dollar suit filed against cell phone firm for causing brain tumours
2. Antibiotics losing their power against acne
3. South Africa Wins landmark case against pharmaceutical giants
4. Vitamin E, the latest warrior against diabetes
5. Acne may protect against infections
6. Fight against E.coli
7. Defence against free radicals
8. Progestin protects against ovarian cancer
9. Beverage protect against bladder cancer
10. Moderate alcohol consumption protects against dementia
11. Broccolis role against cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... , ... Fresh Wave® IAQ today announced the launch of its innovative ... at the APPA 2017 Annual Conference and Exhibition in Booth #414. , ... the use of harsh chemicals, Fresh Wave IAQ Smoke Away Air & Fabric Liquid ...
(Date:7/21/2017)... ... 2017 , ... The Margarian Law Firm has filed a class action ... for allegedly containing no ginger. Dr. Pepper produces the “Canada Dry” brand of ginger ... alleges Canada Dry Ginger Ale claims on its bottle that it is made from ...
(Date:7/21/2017)... ST. LOUIS, MO (PRWEB) , ... July 21, 2017 , ... ... are born knowing how to tie their shoes,” says Suzanne Tucker, Founder of St. ... created the Time-In Toolkit, which launches on Kickstarter on Monday, July 21st. , ...
(Date:7/21/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 21, ... ... repair a torn anterior cruciate ligament (ACL) offer patients improved quality of life ... Orthopaedic Society for Sports Medicine’s Annual Meeting in Toronto, Ontario, Canada. The ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... bone marrow cancer that progresses rapidly without treatment. Newly diagnosed patients face intense ... chance of reoccurrence and relapse. With such a challenging diagnosis that requires ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... , July 21, 2017 Did you know that PhRMA ... 2016? Or that combined spending on brand medicines, generics and the ... with brands accounting for just half of this (7 percent)? Or ... thirds of the world,s venture capital investments in high-growth biopharmaceutical startups? ... ...
(Date:7/19/2017)... , July 19, 2017  Mako Medical Laboratories partnered ... the Military Family Assistance Fund (MFA) to bring 140 ... to visit with their families one last time before ... coordinate the travel and logistics needed for these soldiers. ... soldiers and their families. We just wish we could ...
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based biotechnology company ... the completion of a $12.7 million Series A financing round. ... as the participation of existing investors. ... of New Ventures III and our current investors, and view ... of our platform technology to transform the course of PD ...
Breaking Medicine Technology: